120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer
Palabras clave : 
Breast cancer
Cisplatin
Fluorouracil
Chemotherapy
Fecha incorporación: 
1989
Editorial : 
Lippincott, Williams & Wilkins
ISSN: 
0277-3732
Cita: 
Fernández Hidalgo O, González F, Gil A, Campbell W, Barrajón E, Lacave AJ. 120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer. Am J Clin Oncol. 1989 Oct;12(5):397-401.
Resumen
Thirty-six patients with metastatic breast cancer, 23 with documented progression of the disease after first-line chemotherapy (CAF or CMF) and 13 without prior chemotherapy, were treated with a simultaneous 120-h infusion of cisplatin (CDDP) and 5-fluorouracil (5-FU). Objective response was demonstrated in 19 patients (52.7%), stable disease in 7 patients (19.4%) and progression of the disease in 10 patients (27.7%). Similar response rate was observed according to tumor site (soft tissues, 50%; bone, 52%; lung, 63%; liver, 55%; and pleura and peritoneum, 42%) and previous treatment (previous chemotherapy, 48%; previously untreated, 61%). Median duration of response was 8 months. Toxicity was characterized by stomatitis and myelodepression and required dose adjustments in 30% of patients. CDDP and 5-FU infusion deserve further investigation because it appeared to have substantial activity in this preliminary study in metastatic breast cancer.

Ficheros en este registro:
Fichero: 
Am J Clin Oncol. 1989.397.pdf
Descripción: 
Tamaño: 
375,82 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.